The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

CDDF Multi-stakeholder Workshops in 2023

Save the date for the CDDF Multi-Stakeholder workshops in 2023!

CANCER DRUG DEVELOPMENT FORUM

The leading non-competitive drug development platform working to
stimulate the advancement and accessibility of cancer treatment.

Multi-Stakeholder Interviews: CDDF Workshop on Dose Optimization in Early Oncology Drug Development (3-4 April 2023, NL)

[WATCH THE CDDF’S INTERVIEWS WITH MULTI-STAKEHOLDERS IN ONCOLOGY] The CDDF multi-stakeholder workshop on Dose Optimization in Early Oncology Drug Development (3-4 April 2023, Amsterdam) generated lots of interest and fruitful discussion among meeting attendees from...

[New Publication]: Meeting Report of the Annual Conference 2023

📢 The Cancer Drug Development Forum (CDDF) is happy to inform all stakeholders that its meeting report of the Annual Conference 2023 has been published. The 2023 edition of the multi-stakeholder conference took place on 6-8 February 2023 in Noordwijk aan zee, NL. It...

Executive Summary of the Workshop on “Dose Optimization in Early Oncology Drug Development” (April 2023, Amsterdam)

The Cancer Drug Development Forum (CDDF) has published its executive summary of the workshop on “Dose Optimization in Early Oncology Drug Development.” The multi-stakeholder workshop took place on 3-4 April 2023 in Amsterdam, NL. The gathering brought together the...

Join the CDDF Office Team – Event Coordinator

[CDDF Office: Job vacancy - Event Coordinator] The CDDF is seeking an event coordinator to assist with the organization and delivery of programmes and events, ranging from small workshops and a yearly conference to webinars. Join the CDDF team and work together with...

KEY TAKEAWAYS FROM THE CDDF WEBINAR – REGULATORY CONSIDERATIONS FOR IMMUNOTHERAPY & RADIOTHERAPY COMBINATIONS

[READ KEY TAKEAWAYS FROM THE CDDF WEBINAR] The Cancer Drug Development Forum (CDDF) held a live webinar on the topic of regulatory considerations for Immunotherapy and Radiotherapy Combinations on Monday 27 February 2023. Here are the key takeaways from Prof Paz...

Interviews with the CDDF’s Key Stakeholders

The Cancer Drug Development Forum (CDDF) greatly values all stakeholders’ voices and engagement which help the oncology community break down silos and continue open, meaningful dialogue. To accelerate oncology drug development and deliver optimal treatment to cancer...

CDDF Annual Conference 2023: Executive Summary

📢 The Cancer Drug Development Forum (CDDF) is delighted to inform you that its executive summary of the Annual Conference 2023 has been published and is available to all our stakeholders. The 2023 edition of the multi-stakeholder conference took place on 6-8 February...

CDDF Annual Conference – Day 3

Closing the Annual Conference 2023, we would like to thank all our stakeholders for their engagement and support for our shared mission to improve effective cancer treatment and empower patients. For those interested in our discussion during the last session,...

CDDF Annual Conference 2023 – Day 2

We invite you to take a look at the take-home messages and next steps from yesterday's sessions. SESSION 3: WHAT I SHOULD HAVE ASKED WHEN I STARTED MY CARREER IN CANCER DRUG DEVELOPMENT ❇ Take-Home Messages • It is important to consider where you want your career to...

CDDF Annual Conference 2023 – Day 1

Cancer Drug Development Forum (CDDF) opened the Annual Conference 2023 yesterday with more than 150 people joining onsite and online. Here are the Take-Home Messages from the first day of the Annual Conference: • Diversity can be understood as the combination of...

CDDF Webinar: Regulatory Considerations for Immunotherapy and Radiotherapy Combinations (Feb 2023)

The recording of the recent CDDF webinar on Regulatory Considerations for Immunotherapy and Radiotherapy Combinations is available here. Enjoy the insightful lecture from Prof. Paz Vellanki (FDA) and CDDF’s thought-provoking discussion.

CDDF & Oncology News

Check out the recent updates within the CDDF and the latest news in the community of cancer research

CDDF Brochure

Access the CDDF Brochure here

 

Join the CDDF community to find ways to accelerate oncology drug development and deliver optimal treatment to cancer patients

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70